Pensacola, FL4 Active Studies

Ankylosing Spondylitis Clinical Trials in Pensacola, FL

Find 4 actively recruiting ankylosing spondylitis clinical trials in Pensacola, FL. Connect with local research sites and explore new treatment options.

4
Active Trials
4
Sponsors
3,413
Enrolling

Recruiting Ankylosing Spondylitis Studies in Pensacola

About Ankylosing Spondylitis Clinical Trials in Pensacola

Ankylosing spondylitis is a chronic inflammatory disease primarily affecting the spine and sacroiliac joints, causing pain, stiffness, and potentially spinal fusion. It typically begins in early adulthood. Treatment includes NSAIDs, biologics (TNF and IL-17 inhibitors), and physical therapy.

There are currently 4 ankylosing spondylitis clinical trials recruiting participants in Pensacola, FL. These studies are seeking a combined 3,413 participants. Research is being sponsored by Children's Oncology Group, BioNTech SE, Eli Lilly and Company and 1 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Ankylosing Spondylitis Clinical Trials in Pensacola — FAQ

Are there ankylosing spondylitis clinical trials in Pensacola?

Yes, there are 4 ankylosing spondylitis clinical trials currently recruiting in Pensacola, FL. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Pensacola?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Pensacola research site will contact you about next steps.

Are clinical trials in Pensacola free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Pensacola studies also compensate for your time and travel.

What ankylosing spondylitis treatments are being tested?

The 4 active trials in Pensacola are testing new therapies including novel drugs, biologics, and treatment approaches for ankylosing spondylitis.

Data updated July 22, 2026 from ClinicalTrials.gov